Skip to content

Evaluation of the effectiveness of a simple provocative method for diagnosing occult obstruction in hypertrophic cardiomyopathy

Provocative Maneuvers in Detecting Latent Obstruction: A Multicenter Crossover Randomized Trial of Diagnostic Yield in Hypertrophic Cardiomyopathy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600129370
Enrollment
Unknown
Registered
2026-08-04
Start date
2026-08-10
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertrophic Cardiomyopathy

Interventions

S1:Squat-stand maneuver ? Goal-directed Valsalva(GDV) ? Combined maneuver(GDV + squat-stand maneuver)
S4:GDV ? Combined maneuver ? Squat-stand maneuver
S5:Combined maneuver ? Squat-stand maneuver ? GDV
S6:Combined maneuver ? GDV ? Squat-stand maneuver
S2:Squat-stand maneuver ? Combined maneuver? GDV
S3:GDV ? Squat-stand maneuver ? Combined maneuver

Sponsors

The First Affiliated Hospital of the University of Science and Technology of China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1.Age >= 18 years; 2.Clinically confirmed HCM; 3.Resting left ventricular outflow tract gradient < 30 mmHg; 4.Signed written informed consent.

Exclusion criteria

Exclusion criteria: 1.Known infiltrative or storage disorders causing cardiac hypertrophy or mimicking HCM, such as Fabry disease, amyloidosis, or Noonan syndrome with left ventricular hypertrophy; 2.History of presyncope or syncope; 3.Concurrent acute coronary syndrome; 4.Symptomatic malignant arrhythmias; 5.Refractory hypertension (resting systolic BP > 180 mmHg or diastolic BP > 110 mmHg); 6.Refractory tachycardia or bradycardia; 7.Decompensated symptomatic heart failure; 8.Symptomatic severe aortic stenosis (mean transvalvular gradient = 20 mmHg); 9.Acute pulmonary embolism or deep vein thrombosis; 10.Acute myocarditis/pericarditis; 11.Acute aortic dissection; 12.Other conditions judged by the investigator to preclude the performance of provocative maneuvers; 13.Current or prior treatment with a selective cardiac myosin inhibitor.

Design outcomes

Primary

MeasureTime frame
Left ventricular outflow tract pressure gradient;Detection rate of occult obstruction;

Secondary

MeasureTime frame
Incidence of adverse events;Increments of LVOTG induced by different excitation tests;The diagnostic efficiency of various provocation tests in HCM patients stratified based on cardiac MRI subtypes and NT-proBNP levels;

Countries

China

Contacts

Public ContactChen Kangyu

The First Affiliated Hospital of the University of Science and Technology of China

ahslyycky@126.com+86 551 62284348

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 25, 2026